Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics maker Hibergene has closed a Series B funding round of €6.7 million ($7.2 million), the company announced today. The new funds will expand the firm's research and development programs and its international distributor network.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.